Eli Lilly

Pharmaceuticals · LLY

Maker of tirzepatide (Zepbound, Mounjaro). Its Employer Connect program lists Ilant among 18 administrators steering obesity-drug access.

Market snapshot

NYSE: LLY

1,139.00USD▲ 0.25%+2.89 today

Open · delayed 15 min · Sep 16 4:20 PM EDT · stale

Open: 1,137.31
Mkt cap: 1.02T
High: 1,151.23
Low: 1,132.63
52-wk high: 1,292.65
Dividend: 0.61%
52-wk low: 712.05
Qtrly div amt: 1.73

Day figures as of Sep 16 4:20 PM EDT · previous close 1,136.11

Latest on Eli Lilly

1 story

Featured · Health

This AI startup raised $15 million amid employer cuts to weight-loss drug coverage, but its proof is shaky.

Ilant Health pitches obesity care to employers. Its headline result sets its one-year 15% weight loss against a drug-free program's five-year 5.8%. At one year, that same program reported 12.4%.

September 10, 2026 · 3 min read